Pfizer and Flagship Pioneering are partnering in a drug research alliance leveraging the capabilities of the more than 40 biotech startups in the venture capital firm’s portfolio. The new partners aim to develop drugs for unmet needs, including those in broad patient populations.
Lawmakers have ghost networks in their sights, and payers can prepare now for policy changes.
Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this…
Offering blended options, individual risk pools, and net neutral capitation payments providers can embark on their journey toward value-based care at a pace aligned with…
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly…
Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and…
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
Some specific topics that should be prioritized at all levels
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded…
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
